Skip to content
‹ Back to IndustriesHealthcare

What Should Building Managers Do If COVID Doesn’t Go Away?

We all want the coronavirus to go away and for COVID-19, social distancing and everything that goes with it to be remembered as a horrible part of a weird year. There are some encouraging signs, with Pfizer announcing promising news about a vaccine candidate and other medical companies making progress. But what if the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
What Should Building Managers Do If COVID Doesn’t Go Away?

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

We all want the coronavirus to go away and for COVID-19, social distancing and everything that goes with it to be remembered as a horrible part of a weird year.

There are some encouraging signs, with Pfizer announcing promising news about a vaccine candidate and other medical companies making progress. But what if the vaccine isn’t effective, the virus mutates or it returns in different forms, like the flu?

Those possibilities are why everyone, but especially building managers, must ask the question of what we do if COVID doesn’t go away, said John Shanahan, President of Ionogen.

“Maybe it’s a mutation or maybe the flu gets smarter. We have to have more long-term strategies for getting people back into business,” Shanahan said.

Shanahan has found his company’s hypochlorous solutions highly effective in Ionogen’s own office, with none of his team of 50 testing positive for COVID during the pandemic.

“In February, when this really started to ramp up, we deployed all the humidification devices in our building. Because we made surface sanitizers and disinfectants and they were still trying to figure out what COVID was, we put the air sanitizers up as a preventative measure,” he said. “We were so busy February, March, April and May that there was no stopping. But because we have both the physical staff in our manufacturing division and we needed to be able to collaborate, we just added more units into our space.”

Now, they’re looking into the positive results of hypochlorous actually getting into the upper respiratory areas and potentially killing the virus.

“We’re very excited about the future of where this is going to take us. We will continue, as always, to do more testing and trials and the continued research on this,” Shanahan said. “We’re committed to science, and we like proof. Anecdotes are great, and we’ve got a lot of anecdotes about how this has worked up until now. Now, we’ll continue to dig down into the science. Hypochlorous could very well be the antidote without having to take the immunization.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Oura's $625 million Counsel Health deal puts a ring maker in the triage business

Oura's $625 million Counsel Health deal puts a ring maker in the triage business

Oura is buying Counsel Health for $625 million in cash, bringing an AI chat service with on-demand physicians in-house. Counsel will keep selling triage and virtual care to health plans, health systems and employers. Outcomes data is still to come.

  • 01For $625 million in cash, a smart ring company now owns a service pitched to health plans as a replacement for the nurse triage line.
  • 02Counsel's website offers a free conversation with Counsel AI and lets users add a doctor for $29, a public reference point benefits teams could use when comparing virtual care costs.
  • 03The evidence behind the combined model is member satisfaction (4.6 out of 5) and self-reported surveys; clinical outcomes and cost results are the numbers that would confirm it.

Nov 15, 2026

Ohio State–Microsoft deal, reported at $250M, targets 70–80% of storage/compute to Azure

Ohio State–Microsoft deal, reported at $250M, targets 70–80% of storage/compute to Azure

Ohio State University and Microsoft’s five-year partnership, reported by outlets at $250 million, is largely infrastructure: targeting a shift of roughly 70% to 80% of storage and computing to Azure and building a shared data layer. Note-drafting AI already runs. Smart-room features for patients come later and depend on that foundation.

  • 01The only part of the Ohio State and Microsoft deal with published results is AI note drafting, which saved up to four minutes per visit in Wexner's 2024 pilot.
  • 02Smart-room capabilities (such as personalized lighting) depend on a shared data layer whose high-level design is complete; early measurable returns may show up first in OR and staffing forecasts.
  • 03Health systems weighing a similar platform deal should ask how the headline value breaks down, which workloads move first and whether the cloud copy of the EHR is a backup or the primary record.

Nov 14, 2026

Just 16% of AI-using healthcare organizations fully document model checks after launch, CHIME finds

Just 16% of AI-using healthcare organizations fully document model checks after launch, CHIME finds

CHIME's 2026 Digital Health Most Wired report finds 93.2% of surveyed healthcare organizations use AI. Full generative AI adoption nearly doubled in a year, to 54.8%. Oversight trails: only 16.4% of AI users fully document model monitoring after deployment, making governance the next job for hospital IT leaders.

  • 01Generative AI full adoption went from 31.0% to 54.8% of surveyed healthcare organizations in one year, while only 16.4% of AI users have fully documented processes for monitoring models after launch.
  • 02Organizations that test failover are about twice as likely to restore all critical systems within four hours (45.7% vs. 23.5%), a correlation CHIME reports that highlights where performance differs.
  • 03Smaller organizations trail on prior authorization automation, 28.9% against 49.4% overall, and CMS payer API requirements take effect in January 2027.

Nov 14, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512